Ocular Therapeutix, Inc. (OCUL) Discusses Positive Top Line Results From SOL-1 Phase 3 Trial of AXPAXLI in Wet AMD February 17, 2026 8:00 AM ESTCompany ...
/PRNewswire/ -- Centerspace (NYSE: CSR) (the "Company") announced today its financial and operating results for the year ended December 31, 2025. The tables ...
Generated full year and fourth quarter 2025 consolidated revenue of $1.4 billion and $347 million, respectively Generated full year net income of $21 million ...
/PRNewswire/ -- Quad/Graphics, Inc. (NYSE: QUAD) ("Quad" or the "Company"), a marketing experience company that solves complex marketing challenges for its ...
/PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the following conferences: March 3, 2026, at 11:50am ET at the TD Cowen ...
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the following investor conferences: TD Cowen 46th ...
Fourth Quarter Highlights Fourth quarter 2025 net loss attributable to Huntsman of $96 million compared to a net loss of $141 million in the prior year period;
Lundin Mining Corporation (LUN:CA) Discusses Preliminary Economic Assessment and Development Plan for Vicuna Project February 17, 2026 10:00 AM ESTCompany ...